Salix of Raleigh, N.C., is merging with Italian drugmaker Cosmo Pharmaceuticals, a move that would allow the company to move its tax address to Ireland. If Allergan acquired Salix, it might also be able to move its tax address to Ireland and reduce its tax expenses
Unlike Valeant, we can afford what we buy--we do not go into debt. We do not cripple R&D. Valeant would do well to copy Allergan.
A scientific company who's only idea is slashing R&D spending for short-term stock-market gains... I hope Allergan never copies Valeant disaster of a business model.